Randomized, Double-Blind, Placebo-Controlled Crossover Trials of Venlafaxine for Hot Flashes After Breast Cancer-Reference-Cited by-同舟云学术

Randomized, Double-Blind, Placebo-Controlled Crossover Trials of Venlafaxine for Hot Flashes After Breast Cancer

Published:2007-01-01 Issue:1 Volume:12 Page:124-135
ISSN:1083-7159
Container-title:The Oncologist
language:en
Short-container-title:

Author:

Carpenter Janet S.¹,Storniolo Anna Maria¹,Johns Shelley¹,Monahan Patrick O.¹,Azzouz Faouzi¹,Elam Julie L.¹,Johnson Cynthia S.¹,Shelton Richard C.²

Affiliation:

1. a Indiana University, Indianapolis, Indiana, USA

2. b Vanderbilt University, Nashville, Tennessee, USA

Abstract

Learning Objectives After completing this course, the reader will be able to: Discuss the efficacy of venlafaxine in alleviating hot flashes and improving secondary outcomes.Identify the week of treatment that venlafaxine was most effective.List three side effects associated with venlafaxine. CME Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com

Funder

NIH, National Institute of Nursing Research

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1634/theoncologist.12-1-124

Reference51 articles.

1. The prevalence of menopausal symptoms in patients treated for breast cancer;Canney;Clin Oncol (R Coll Radiol),1994

2. Prevalence and treatment of menopausal symptoms among breast cancer survivors;Harris;J Pain Symptom Manage,2002

3. State of the science: Hot flashes and cancer. Part 1: Definition, scope, impact, physiology, and measurement;Carpenter;Oncol Nurs Forum,2005